Home › Funds › RTW INVESTMENTS, LP › CYTK

RTW INVESTMENTS, LP position in CYTK

CYTOKINETICS INC · Health Care

RTW INVESTMENTS, LP reported holding 2,862,003 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$188.6M, representing 1.90% of its reported portfolio and ranking #17 among its reported holdings. RTW INVESTMENTS, LP has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.86M sh
Reported value held$188.63M
Portfolio Weight1.90%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How RTW INVESTMENTS, LP's CYTK position evolved

RTW INVESTMENTS, LP first disclosed a stake in CYTK in Q3 2023 at 2,574,198 shares (US$75.8M). The position peaked in Q2 2026 at 2,862,003 shares, worth US$243.8M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 2,862,003 shares valued at US$188.6M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.57M $75.84M New
Q4 2023 2.53M $210.82M Reduce
Q1 2024 2.53M $177.03M Hold
Q2 2024 2.72M $147.43M Add
Q3 2024 2.72M $143.68M Hold
Q4 2024 2.72M $128.00M Hold
Q1 2025 2.72M $109.36M Hold
Q2 2025 2.72M $89.91M Hold
Q3 2025 2.72M $149.55M Hold
Q4 2025 2.72M $172.90M Hold
Q1 2026 2.72M $179.35M Hold
Q2 2026 2.86M $243.81M Add
Q3 2026 2.86M $188.63M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CYTK and 13F data

CYTK (CYTOKINETICS INC) is a Health Care company. 39 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CYTK

All CYTK fund holders →

FAQ

How long has RTW INVESTMENTS, LP held CYTK?

RTW INVESTMENTS, LP has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is RTW INVESTMENTS, LP's current position in CYTK?

As of Q3 2026, RTW INVESTMENTS, LP holds 2.86M shares of CYTK (CYTOKINETICS INC), valued at $188.63M, representing 1.90% of its reported portfolio and ranking #17.

Has RTW INVESTMENTS, LP been buying or selling CYTK?

In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in CYTK. The position peaked in Q2 2026 at 2.86M shares.

Which other funds hold CYTK?

Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.